|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12...910111213141516171819...3940» |
- methylphenidate tablet / Generic mfg.
Trial completion, Trial primary completion date: Psychopharmacology for Cocaine Dependence - Buspirone (clinicaltrials.gov) - Jun 15, 2015
P1/2, N=40, Completed, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Dec 2014
- aspirin / Generic mfg.
Trial primary completion date: Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers (clinicaltrials.gov) - Jun 11, 2015
P2, N=56, Recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Dec 2014 Trial primary completion date: Jun 2015 --> Dec 2015
- Trial primary completion date: Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress (clinicaltrials.gov) - Jun 11, 2015
P1, N=66, Recruiting, Sponsor: Medical University of South Carolina
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Feb 2015 --> Jan 2016
- || Trial primary completion date: SBIRT-PC: Screening, Brief Intervention, and Referral to Treatment in Primary Care (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=120, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Feb 2015 --> Jan 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- Buprenex (buprenorphine) / Reckitt Benckiser
Trial primary completion date: MOPPlus: Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines (clinicaltrials.gov) - Jun 11, 2015
P1, N=40, Recruiting, Sponsor: Thomas Jefferson University
Trial primary completion date: Jun 2015 --> Jun 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- || Trial primary completion date: CM ETG: Contingency Management of Alcohol Abuse in the Severely Mentally ILL (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=120, Recruiting, Sponsor: University of Washington
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Dec 2014 --> Sep 2015
- |||| hydromorphone hydrochloride / Generic mfg.
Trial primary completion date: Study to Assess Longer-term Opioid Medication Effectiveness (SALOME) (clinicaltrials.gov) - Jun 11, 2015
P3, N=202, Active, not recruiting, Sponsor: University of British Columbia
Trial primary completion date: Dec 2014 --> Sep 2015 Trial primary completion date: Jan 2015 --> Jun 2014
- bupropion sustained-release / Generic mfg.
Trial termination: Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia (clinicaltrials.gov) - Jun 11, 2015
P4, N=17, Terminated, Sponsor: Massachusetts General Hospital
Trial primary completion date: Jan 2015 --> Jun 2014 Completed --> Terminated
- Enrollment closed: Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients (clinicaltrials.gov) - Jun 10, 2015
P=N/A, N=600, Active, not recruiting, Sponsor: University of California, San Francisco
Completed --> Terminated Recruiting --> Active, not recruiting
- naltrexone / Generic mfg.
Enrollment closed: Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism (clinicaltrials.gov) - Jun 6, 2015
P4, N=160, Active, not recruiting, Sponsor: Medical University of South Carolina
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Chantix (varenicline) / Pfizer
Enrollment change: Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal (clinicaltrials.gov) - Jun 4, 2015
P4, N=0, Withdrawn, Sponsor: VA Boston Healthcare System
Recruiting --> Active, not recruiting N=30 --> 0
- |||| Sublocade (buprenorphine once-monthly depot) / Indivior
Trial completion, Enrollment change: Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects (clinicaltrials.gov) - Jun 4, 2015
P2, N=124, Completed, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.
N=30 --> 0 Active, not recruiting --> Completed | N=90 --> 124
- Trial completion: Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth (clinicaltrials.gov) - Jun 4, 2015
P=N/A, N=800, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Active, not recruiting --> Completed | N=90 --> 124 Recruiting --> Completed
- Trial completion, Trial primary completion date: Tobacco Treatment Medical Education in 10 Medical Schools (clinicaltrials.gov) - Jun 3, 2015
P=N/A, N=10, Completed, Sponsor: University of Massachusetts, Worcester
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> May 2014
- ||| Trial completion, Trial primary completion date: Computer-Based Alcohol Use Disorder Recovery System (clinicaltrials.gov) - Jun 3, 2015
P=N/A, N=350, Completed, Sponsor: University of Wisconsin, Madison
Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> May 2014 Active, not recruiting --> Completed | Trial primary completion date: Sep 2014 --> Oct 2012
- |||| Trial completion: Helping Those With Mental Illness Quit Smoking (clinicaltrials.gov) - Jun 2, 2015
P4, N=272, Completed, Sponsor: University of Wisconsin, Madison
Active, not recruiting --> Completed | Trial primary completion date: Sep 2014 --> Oct 2012 Active, not recruiting --> Completed
- Enrollment change: CTAP: Couple-Based Treatment for Alcohol Use Disorders and Post-Traumatic Stress Disorder (clinicaltrials.gov) - May 28, 2015
P1, N=13, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed N=100 --> 13
- Trial completion: Phone Interview to Prevent Recurring Opioid Overdoses (clinicaltrials.gov) - May 28, 2015
P=N/A, N=30, Completed, Sponsor: University of Cincinnati
N=100 --> 13 Enrolling by invitation --> Completed
- |||| methadone / Generic mfg.
Trial completion: Permit: Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment (clinicaltrials.gov) - May 28, 2015
P4, N=189, Completed, Sponsor: Universit
Enrolling by invitation --> Completed Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: TRAC: A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults (clinicaltrials.gov) - May 27, 2015
P=N/A, N=765, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Nov 2014
- |||| Trial completion: Efficacy Trial of Warrior Check-Up (clinicaltrials.gov) - May 27, 2015
P2, N=242, Completed, Sponsor: University of Washington
Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Nov 2014 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: B-SAFER: Brief Intervention for Substance Use and Partner Abuse Among Females in the ER (clinicaltrials.gov) - May 22, 2015
P=N/A, N=40, Completed, Sponsor: Rhode Island Hospital
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Feb 2015 --> Nov 2014
- Enrollment open, Trial initiation date: CAR-Bern 2013: Acute Effects of Cortisol on Alcohol Craving in Alcohol Dependence (clinicaltrials.gov) - May 21, 2015
P3, N=40, Recruiting, Sponsor: University Hospital Inselspital, Berne
Recruiting --> Completed | Trial primary completion date: Feb 2015 --> Nov 2014 Not yet recruiting --> Recruiting | Initiation date: Aug 2014 --> Nov 2014
- Enrollment closed, Enrollment change, Trial primary completion date: A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers (clinicaltrials.gov) - May 21, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting --> Recruiting | Initiation date: Aug 2014 --> Nov 2014 Recruiting --> Active, not recruiting | N=180 --> 30 | Trial primary completion date: May 2016 --> May 2015
- Trial completion, Enrollment change: Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care (clinicaltrials.gov) - May 20, 2015
P=N/A, N=30, Completed, Sponsor: New York State Psychiatric Institute
Recruiting --> Active, not recruiting | N=180 --> 30 | Trial primary completion date: May 2016 --> May 2015 Active, not recruiting --> Completed | N=60 --> 30
- ||| Trial completion, Phase classification, Trial primary completion date: Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User (clinicaltrials.gov) - May 19, 2015
P=N/A, N=152, Completed, Sponsor: Macmillan Research Group UK
Active, not recruiting --> Completed | N=60 --> 30 Not yet recruiting --> Completed | Phase classification: P2 --> PN/A | Trial primary completion date: Nov 2014 --> Mar 2015
- Trial completion: CTAP: Couple-Based Treatment for Alcohol Use Disorders and Post-Traumatic Stress Disorder (clinicaltrials.gov) - May 19, 2015
P1, N=100, Completed, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Completed | Phase classification: P2 --> PN/A | Trial primary completion date: Nov 2014 --> Mar 2015 Recruiting --> Completed
- |||| buprenorphine/naloxone sublingual film / Generic mfg., buprenorphine sublingual tablets / Generic mfg.
Trial completion, Trial primary completion date: Transfer of Subjects From Subutex/Suboxone to RBP-6300 (clinicaltrials.gov) - May 16, 2015
P2, N=143, Completed, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jul 2013 --> Nov 2012
- Phase classification: Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD) (clinicaltrials.gov) - May 14, 2015
P=N/A, N=110, Completed, Sponsor: The City College of New York
Active, not recruiting --> Completed | Trial primary completion date: Jul 2013 --> Nov 2012 Phase classification: P1/2 --> P=N/A
- || Enrollment closed: CTN 0059: The Tobacco, Alcohol, Prescription Medication and Other Substances Tool (clinicaltrials.gov) - May 14, 2015
P=N/A, N=2000, Active, not recruiting, Sponsor: Friends Research Institute, Inc.
Phase classification: P1/2 --> P=N/A Recruiting --> Active, not recruiting
- Enrollment open: Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs) (clinicaltrials.gov) - May 13, 2015
P=N/A, N=300, Recruiting, Sponsor: Andrew Quanbeck
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Enrollment closed: Home-Based Program to Help Parents of Drug Abusing Adolescents (clinicaltrials.gov) - May 13, 2015
P=N/A, N=450, Active, not recruiting, Sponsor: Treatment Research Institute
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion: Developing an Intervention to Address Suicide Risk During Substance Use Disorder (clinicaltrials.gov) - May 13, 2015
P=N/A, N=56, Completed, Sponsor: University of Michigan
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| Trial completion: Tobacco Cessation Field Study for Adults in Recovery - 1 (clinicaltrials.gov) - May 13, 2015
P2, N=203, Completed, Sponsor: Inflexxion, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment closed, HEOR: Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (clinicaltrials.gov) - May 12, 2015
P=N/A, N=150, Active, not recruiting, Sponsor: Wayne State University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial primary completion date: PC: Web Intervention for Concerned Partners to Prevent Service Member Alcohol Abuse Abuse (clinicaltrials.gov) - May 8, 2015
P=N/A, N=100, Recruiting, Sponsor: RAND
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2015 --> May 2016
- Enrollment open: Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use. (clinicaltrials.gov) - May 7, 2015
P=N/A, N=100, Recruiting, Sponsor: Rambam Health Care Campus
Trial primary completion date: Sep 2015 --> May 2016 Not yet recruiting --> Recruiting
- Enrollment open: Integrated Collaborative Care for Substance Use Disorders (clinicaltrials.gov) - May 6, 2015
P=N/A, N=400, Recruiting, Sponsor: RAND
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- lorazepam / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) (clinicaltrials.gov) - May 5, 2015
P4, N=150, Recruiting, Sponsor: Denver Health and Hospital Authority
Not yet recruiting --> Recruiting Trial primary completion date: Mar 2015 --> Mar 2017
- Trial completion, Enrollment change: Electronic Cigarettes in Daily Dependent Smokers (clinicaltrials.gov) - May 5, 2015
P4, N=43, Completed, Sponsor: Centre for Addiction and Mental Health
Trial primary completion date: Mar 2015 --> Mar 2017 Recruiting --> Completed | N=30 --> 43
- Trial completion: Nicotine Patch for Marijuana Withdrawal (clinicaltrials.gov) - May 2, 2015
P4, N=127, Completed, Sponsor: Southern Illinois University Carbondale
Recruiting --> Completed | N=30 --> 43 Recruiting --> Completed
- Sativex (nabiximols) / Jazz
Enrollment closed, Trial primary completion date: Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence (clinicaltrials.gov) - May 1, 2015
P2, N=45, Active, not recruiting, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Oct 2015
- || Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
Enrollment closed, Trial primary completion date: INSPIRE: Alcohol Pharmacotherapy for HIV+ Prisoners (clinicaltrials.gov) - May 1, 2015
P=N/A, N=125, Active, not recruiting, Sponsor: Yale University
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Oct 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Aug 2016
- Trial completion, Enrollment change: BP: Blister Packaging Medication to Increase Treatment Adherence and Clinical Response (clinicaltrials.gov) - May 1, 2015
P=N/A, N=303, Completed, Sponsor: VA Eastern Colorado Health Care System
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Aug 2016 Active, not recruiting --> Completed | N=419 --> 303
- Enrollment change, Trial withdrawal, Trial primary completion date: Biofeedback for Adolescent Cannabis Use Disorder (clinicaltrials.gov) - Apr 30, 2015
P1/2, N=0, Withdrawn, Sponsor: Denver Health and Hospital Authority
Active, not recruiting --> Completed | N=419 --> 303 N=30 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2015 --> Sep 2014
- emricasan (IDN 6556) / Amerimmune
Enrollment change, Trial termination: Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF (clinicaltrials.gov) - Apr 30, 2015
P2, N=23, Terminated, Sponsor: Conatus Pharmaceuticals Inc.
N=30 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2015 --> Sep 2014 N=60 --> 23 | Active, not recruiting --> Terminated; Data needs met
- || Trial primary completion date: REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) (clinicaltrials.gov) - Apr 29, 2015
P2, N=72, Recruiting, Sponsor: Pharmicell Co., Ltd.
N=60 --> 23 | Active, not recruiting --> Terminated; Data needs met Trial primary completion date: Jan 2015 --> Sep 2015
- |||| metadoxine / Generic mfg.
Trial completion, Trial primary completion date: Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis (clinicaltrials.gov) - Apr 29, 2015
P2, N=90, Completed, Sponsor: PharmaKing
Trial primary completion date: Jan 2015 --> Sep 2015 Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Dec 2014
- Trial completion: ITSAN: Integrating Interventions for Maternal Substance Abuse (clinicaltrials.gov) - Apr 29, 2015
P1, N=31, Completed, Sponsor: Oregon Social Learning Center
Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Dec 2014 Recruiting --> Completed
- Trial primary completion date: Tailored Mobile Text Messaging to Reduce Problem Drinking (clinicaltrials.gov) - Apr 28, 2015
P=N/A, N=300, Recruiting, Sponsor: North Shore Long Island Jewish Health System
Recruiting --> Completed Trial primary completion date: Jan 2015 --> Jul 2015